Review examines how nanostructuring improves osseointegration in zirconia implants, suggesting implications for clinical use.
Objectives To critically examine recent advances in nanoscale surface-engineering strategies designed to enhance the osseointegration and biological performance of zirconia dental implants. This review integrates current in vitro, in vivo, and emerging clinical evidence to clarify how nanostructuring influences protein adsorption, cellular responses, and implant stability. Data Sources A comprehensive search of PubMed, Scopus, Web of Science, and Google Scholar was conducted to identify relevant literature on nanostructured zirconia implants. Additional sources included reference lists of key articles, recent reviews, and experimental studies addressing surface modification, osseointegration mechanisms, and biomimetic approaches. Study Selection Included studies encompassed in vitro, animal, and clinical investigations evaluating nanoscale modifications of zirconia surfaces. Techniques analyzed comprised anodization, laser texturing, sol–gel coatings, UV photofunctionalization, hydroxyapatite and bioactive glass deposition, and hybrid treatments. Priority was given to studies reporting biological outcomes such as osteoblast adhesion, proliferation, differentiation, antimicrobial activity, and bone–implant contact (BIC). Conclusions Nanoscale modifications substantially improve the biological interaction between zirconia implants and surrounding tissues by enhancing protein adsorption, wettability, osteoblast function, and early bone formation. While preclinical findings are highly encouraging, long-term human clinical data and scalable manufacturing processes are still required to enable widespread clinical translation. Clinical Significance Nanostructured zirconia implants demonstrate superior early healing, improved osseointegration, and reduced bacterial adhesion compared with conventional surfaces. These advantages may shorten recovery periods, support earlier loading, and enhance long-term clinical outcomes, positioning nanostructured zirconia as a promising, esthetic, and biologically advanced alternative to traditional titanium implant systems.
No takes yet. Share an insight, caveat, or question.
Ghazal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: